Source: http://www.google.com/patents/US5904717?dq=5463388
Timestamp: 2018-01-17 19:18:42
Document Index: 602268320

Matched Legal Cases: ['art 1', 'art 1', 'art 2', 'art 2', 'art 2', 'art 2', 'art 1', 'art 1', 'art 1', 'art 1', 'art 2', 'art 2', 'art 2', 'art 2', 'art 1', 'art 1']

Patent US5904717 - Method and device for reconstruction of articular cartilage - Google Patents
A biodegradable device for facilitating healing of structural voids in bone, cartilage as well as soft tissue is disclosed in the most preferred form including a porous macrostructure made from a biodegradable polymer and a chemotactic ground substance in the form of an RGD attachment moiety of fibronectin...http://www.google.com/patents/US5904717?utm_source=gb-gplus-sharePatent US5904717 - Method and device for reconstruction of articular cartilage
Publication number US5904717 A
Application number US 08/370,161
Publication number 08370161, 370161, US 5904717 A, US 5904717A, US-A-5904717, US5904717 A, US5904717A
Patent Citations (54), Non-Patent Citations (74), Referenced by (95), Classifications (43), Legal Events (8)
US 5904717 A
1 * Application of Porous Ceramics for the Attachment of Load Bearing Internal Orthopedic Applications, J.J. Klawitter et al., Bioceramics Engineering in Medicine (Part 1), J. Biomedical Materials Symposium, No. 2, pp. 161 129 (1972).
2 Application of Porous Ceramics for the Attachment of Load Bearing Internal Orthopedic Applications, J.J. Klawitter et al., Bioceramics--Engineering in Medicine (Part 1), J. Biomedical Materials Symposium, No. 2, pp. 161-129 (1972).
3 * Attachment and survival of perichondrocytes in a porous polylactic acid (PLA) matrix: an in vitro study, by C.R. Chu, A.Z. Monosov, R.D. Coutts, and D. Amiel, Thirteenth Southern Biomedical Engineering Conference, Apr. 16 17, 1994, University of the District of Columbia, Washington, D.C.
4 Attachment and survival of perichondrocytes in a porous polylactic acid (PLA) matrix: an in vitro study, by C.R. Chu, A.Z. Monosov, R.D. Coutts, and D. Amiel, Thirteenth Southern Biomedical Engineering Conference, Apr. 16-17, 1994, University of the District of Columbia, Washington, D.C.
5 * Bioceramics Engineering in Medicine (Part 2), J. Biomedical Materials Symposium, R. Topazian et al., No. 2 (Part 2), pp. 311 332 (1972).
6 Bioceramics--Engineering in Medicine (Part 2), J. Biomedical Materials Symposium, R. Topazian et al., No. 2 (Part 2), pp. 311-332 (1972).
7 Bioresorbability and Biocompatibility of Aliphatic Polyesters, M. Vert et al., Journal of Materials Science: Materials in Medicine 3, ©1992 Chapman & Hall, pp. 432-446.
8 * Bioresorbability and Biocompatibility of Aliphatic Polyesters, M. Vert et al., Journal of Materials Science: Materials in Medicine 3, 1992 Chapman & Hall, pp. 432 446.
9 * Calcium Phosphate Ceramics as Hard Tissue Prosthetics, Michael Jarcho, PH.D., Clinical Orthopaedics and Related Research, No. 157, pp. 259 278 (1981).
10 Calcium Phosphate Ceramics as Hard Tissue Prosthetics, Michael Jarcho, PH.D., Clinical Orthopaedics and Related Research, No. 157, pp. 259-278 (1981).
11 * Compatibility of Porous Ceramics with Soft Tissue; Application to Tracheal Prosthesis, S.F. Hulbert et al., Bioceramics Engineering in Medicine (Part 1), J. Biomedical Materials Symposium, vol. 2, (Part 1), pp. 269 279 (1972).
12 Compatibility of Porous Ceramics with Soft Tissue; Application to Tracheal Prosthesis, S.F. Hulbert et al., Bioceramics--Engineering in Medicine (Part 1), J. Biomedical Materials Symposium, vol. 2, (Part 1), pp. 269-279 (1972).
13 * Compressive Characteristics of Freeze Dried Agar and Alginate Gel, A. Nussinovitch et al., Biotechnol Prog, pp. 101 104 (1993).
14 Compressive Characteristics of Freeze-Dried Agar and Alginate Gel, A. Nussinovitch et al., Biotechnol Prog, pp. 101-104 (1993).
15 * Culture and differentiation of chondrocytes entrapped in alginate gels, by M. Grandolfo, P. D Andrea, S. Paoletti, M. Martina, G. Silvestrini, E. Bonucci, and F. Vittur, Calcif. Tissue Int., 52, pp. 42 48, (1993).
16 Culture and differentiation of chondrocytes entrapped in alginate gels, by M. Grandolfo, P. D'Andrea, S. Paoletti, M. Martina, G. Silvestrini, E. Bonucci, and F. Vittur, Calcif. Tissue Int., 52, pp. 42-48, (1993).
17 David H. Cormach, "Ham's Histology", Nineth Edition, ©1987, J.B. Lippincutt Company, pp. 325-326.
18 * David H. Cormach, Ham s Histology , Nineth Edition, 1987, J.B. Lippincutt Company, pp. 325 326.
19 * Development of Ceramic and Ceramic Composite Devices for Maxillofacial Applications, T.D. Driskell et al., Bioceramics Engineering in Medicine (Part 2), J. Biomedical Materials Symposium, No. 2 (Part 2), pp. 345 361 (1972).
20 Development of Ceramic and Ceramic Composite Devices for Maxillofacial Applications, T.D. Driskell et al., Bioceramics--Engineering in Medicine (Part 2), J. Biomedical Materials Symposium, No. 2 (Part 2), pp. 345-361 (1972).
21 * Developmental Role of Hyaluronate, Bryan P. Toole, Connective Tissue Research, vol. 10, pp. 93 100 (1982).
22 Developmental Role of Hyaluronate, Bryan P. Toole, Connective Tissue Research, vol. 10, pp. 93-100 (1982).
23 * Effect of freeze dried poly L lactic acid discs mixed with bone morphogenetic protein on the healing of rat skull defects by T. Miki, K. Harada, Y. Imai, and S. Enomoto, J. Oral Maxillofac. Surg., 52, pp. 387 391, (1994).
24 Effect of freeze-dried poly-L-lactic acid discs mixed with bone morphogenetic protein on the healing of rat skull defects by T. Miki, K. Harada, Y. Imai, and S. Enomoto, J. Oral Maxillofac. Surg., 52, pp. 387-391, (1994).
25 * Effect of Surgical Trauma and Polylactate Cubes and Granules on the Incidence of Alveolar Osteitis in Madibular Third Molar Extraction Wounds, John Brekke et al, J. Canad Dent Assn, No. 4, pp. 315 319 (1986).
26 Effect of Surgical Trauma and Polylactate Cubes and Granules on the Incidence of Alveolar Osteitis in Madibular Third Molar Extraction Wounds, John Brekke et al, J. Canad Dent Assn, No. 4, pp. 315-319 (1986).
27 * Effect of the Structure of Poly(Glycol Monomethacrylate) Gel on the Calcification of Implants, L. Sprinel et al., Calc. Tiss., Res. 13, pp. 63 72 (1973).
28 Effect of the Structure of Poly(Glycol Monomethacrylate) Gel on the Calcification of Implants, L. Sprinel et al., Calc. Tiss., Res. 13, pp. 63-72 (1973).
29 * Evidence for the existence of hyaluronectin binding proteins in the plasma membranes, Sanjay Gupta et al., FEBS 13470, vol. 336, pp. 511 515 (1993).
30 Evidence for the existence of hyaluronectin-binding proteins in the plasma membranes, Sanjay Gupta et al., FEBS 13470, vol. 336, pp. 511-515 (1993).
31 * Expression and modulation of CD44 variant isoforms in humans, by C.R. Mackay, H J. Terpe, R. Stauder, W.L. Marston, H. Stark and U. G u nthert, J. Cell Bio., 124 (1&2), pp. 71 82, (Jan. 1994).
32 Expression and modulation of CD44 variant isoforms in humans, by C.R. Mackay, H-J. Terpe, R. Stauder, W.L. Marston, H. Stark and U. Gunthert, J. Cell Bio., 124 (1&2), pp. 71-82, (Jan. 1994).
33 * Guidor, The Bioresorbable Matrix Barrier, pp. 1 33 (1993).
34 Guidor, The Bioresorbable Matrix Barrier, pp. 1-33 (1993).
35 * Healing of Hyaluronic Acid Enriched Wounds: Histological Observations, G. Abatangelo et al., Journal of Surgical Research 35, pp. 410 416 (1983).
36 Healing of Hyaluronic Acid-Enriched Wounds: Histological Observations, G. Abatangelo et al., Journal of Surgical Research 35, pp. 410-416 (1983).
37 * Human Bone Morphongenetic Protein, Marshall R. Urist et al., Proceedings of the Society for Experimental Biology and Medicine 173, pp. 194 199 (1983).
38 Human Bone Morphongenetic Protein, Marshall R. Urist et al., Proceedings of the Society for Experimental Biology and Medicine 173, pp. 194-199 (1983).
39 * Hyaluronate can function as a cell adhesion molecule and CD44 participates in hyaluronate recognition, by K. Miyake, C.B. Underhill, J. Lesley, and P.W. Kincade, J. Exp. Med., 172, pp. 69 75, (1990).
40 Hyaluronate can function as a cell adhesion molecule and CD44 participates in hyaluronate recognition, by K. Miyake, C.B. Underhill, J. Lesley, and P.W. Kincade, J. Exp. Med., 172, pp. 69-75, (1990).
41 * Identification of hyaluronic acid binding sites in the extracellular domain of CD44, by R.J. Peach, D. Hollenbaugh, I. Stamenkovic, and A. Aruffo, J. Cell Bio., 122 (1), pp. 257 264 (Jul. 1993).
42 Identification of hyaluronic acid binding sites in the extracellular domain of CD44, by R.J. Peach, D. Hollenbaugh, I. Stamenkovic, and A. Aruffo, J. Cell Bio., 122 (1), pp. 257-264 (Jul. 1993).
43 * In vivo degradation of massive poly(a hydroxy acids): validation of in vitro findings, M. Therin et al., Biomaterials vol. 13, No. 9, 1992 pp. 594 600.
44 In vivo degradation of massive poly(a-hydroxy acids): validation of in vitro findings, M. Therin et al., Biomaterials vol. 13, No. 9, ©1992 pp. 594-600.
45 * Influence of matricial molecules on growth and differentiation of entrapped chondrocytes, by H. Ramdi, C. Legar, and M. Lievremont, Experi. Cell Res., 207, pp. 449 454, (1993).
46 Influence of matricial molecules on growth and differentiation of entrapped chondrocytes, by H. Ramdi, C. Legar, and M. Lievremont, Experi. Cell Res., 207, pp. 449-454, (1993).
47 * Influence of polylactic acid mesh on the incidence of localized osteitis, John H. Brekke et al., Oral Surg., vol. 56, No. 3, pp. 240 245 (1983).
48 Influence of polylactic acid mesh on the incidence of localized osteitis, John H. Brekke et al., Oral Surg., vol. 56, No. 3, pp. 240-245 (1983).
49 * Laminated three dimensional biodegradable foams for use in tissue engineering, by A.G. Mikos, G. Sarakinos, S.M. Leite, J.P. Vacanti, and R. Langer, Biomat., 14 (5), pp. 323 330, (1993).
50 Laminated three-dimensional biodegradable foams for use in tissue engineering, by A.G. Mikos, G. Sarakinos, S.M. Leite, J.P. Vacanti, and R. Langer, Biomat., 14 (5), pp. 323-330, (1993).
51 * Mechanisms of polymer degradation in implantable devices. 2. Poly(DL lactic acid), S.A.M. Ali et al., Journal of Biomedical Materials Research, vol. 27, 1993 pp. 1409 1418.
52 Mechanisms of polymer degradation in implantable devices. 2. Poly(DL-lactic acid), S.A.M. Ali et al., Journal of Biomedical Materials Research, vol. 27, ©1993 pp. 1409-1418.
53 * New Insights on the Degradation of Bioresorbable Polymeric Devices Based on Lactic and Glycolic Acids, Vert et al., Clinical Materials 10, 1992 pp. 3 8.
54 New Insights on the Degradation of Bioresorbable Polymeric Devices Based on Lactic and Glycolic Acids, Vert et al., Clinical Materials 10, 1992 pp. 3-8.
55 * Porous polymer implants for repair of full thickness defects of articular cartilage: an experimental study in rabbit and dog, by J. Klompmaker, H.W.B. Jansen, R.P.H. Veth, H.K.L. Nielsen, J.H. de Groot, and A.J. Pennings, Biomat., 13 (9), pp. 625 634, (1992).
56 Porous polymer implants for repair of full-thickness defects of articular cartilage: an experimental study in rabbit and dog, by J. Klompmaker, H.W.B. Jansen, R.P.H. Veth, H.K.L. Nielsen, J.H. de Groot, and A.J. Pennings, Biomat., 13 (9), pp. 625-634, (1992).
57 * Preparation of poly(glycolic acid) bonded fiber structures for cell attachment and transplantation, by A.G. Mikos, Y. Bao, L.G. Cima, D.E. Ingber, J.P. Vacanti, and R. Langer, J. Biomed. Mat. Res., 27, pp. 183 189, (1993).
58 Preparation of poly(glycolic acid) bonded fiber structures for cell attachment and transplantation, by A.G. Mikos, Y. Bao, L.G. Cima, D.E. Ingber, J.P. Vacanti, and R. Langer, J. Biomed. Mat. Res., 27, pp. 183-189, (1993).
59 * Rabbit articular chondrocytes in alginate gel: characterisation of immobilized preparations and potential applications, by C. Tamponnet, H. Ramdi, J B. Guyot, and M. Lievremont, Appl. Microbiol. Biotechnol., 37, pp. 311 315, (1992).
60 Rabbit articular chondrocytes in alginate gel: characterisation of immobilized preparations and potential applications, by C. Tamponnet, H. Ramdi, J-B. Guyot, and M. Lievremont, Appl. Microbiol. Biotechnol., 37, pp. 311-315, (1992).
61 * Resorbable Ceramic Implants, G.A. Graves et al., Bioceramics Engineering in Medicine (Part 1), J. Biomedical Materials Symposium, No. 2, pp. 91 115 (1972).
62 Resorbable Ceramic Implants, G.A. Graves et al., Bioceramics--Engineering in Medicine (Part 1), J. Biomedical Materials Symposium, No. 2, pp. 91-115 (1972).
63 * Sato et al., Pharm. Res., 5 (1), 21 30, 1988, Porous biodegradable microspheres for controlled drug delivery.
64 Sato et al., Pharm. Res., 5 (1), 21-30, 1988, Porous biodegradable microspheres for controlled drug delivery.
65 * Synthesis and turnover of proteoglycans by human and bovine adult articular chondrocytes cultured in alginate beads, by H.J. Hauselmann, M.B. Aydelotte, B.L. Schumacher, K.E. Kuettner, S.H. Gitelis, and E.J. M.A. Thonar, Matrix, 12, pp. 116 129, (1992).
66 Synthesis and turnover of proteoglycans by human and bovine adult articular chondrocytes cultured in alginate beads, by H.J. Hauselmann, M.B. Aydelotte, B.L. Schumacher, K.E. Kuettner, S.H. Gitelis, and E.J.-M.A. Thonar, Matrix, 12, pp. 116-129, (1992).
67 * The Effect of the Addition of Low Molecule Weight Poly(DL lactide) on Drug Release from Biodegradable Poly(DL lactide) Drug delivery Systems, R. Bodmeier et al., International Journal of Pharmaceutics, 51, pp. 1 9 (1989).
68 The Effect of the Addition of Low Molecule Weight Poly(DL-lactide) on Drug Release from Biodegradable Poly(DL-lactide) Drug delivery Systems, R. Bodmeier et al., International Journal of Pharmaceutics, 51, pp. 1-9 (1989).
69 * Towards a synthetic articular cartilage, by P.H. Corkhill, J.H. Fitton, and B.J. Tighe, J. Biomater. Sci. Polymer Edn., 4 (6), pp. 615 630, (1993).
70 Towards a synthetic articular cartilage, by P.H. Corkhill, J.H. Fitton, and B.J. Tighe, J. Biomater. Sci. Polymer Edn., 4 (6), pp. 615-630, (1993).
71 * tricalcium Phosphate Delivery System for Bone Morphogenetic Protein, Marshall R. Urist et al., Clinical Orthopaedics and Related Research, No. 187, pp. 277 280 (1984).
72 * Urist et al., Proc. Natl. Acad. Sci. USA, vol. 81, Jan. 1984 pp. 371 375, Purification of Bovine Bone Morphogenetic Protein by Hydroxyapatite Chromatograph.
73 Urist et al., Proc. Natl. Acad. Sci. USA, vol. 81, Jan. 1984 pp. 371-375, Purification of Bovine Bone Morphogenetic Protein by Hydroxyapatite Chromatograph.
74 β-tricalcium Phosphate Delivery System for Bone Morphogenetic Protein, Marshall R. Urist et al., Clinical Orthopaedics and Related Research, No. 187, pp. 277-280 (1984).
US6683064 Sep 17, 2001 Jan 27, 2004 Depuy Acromed, Inc. Cross-linked polysaccharide drug carrier
US6953784 Oct 3, 2003 Oct 11, 2005 Depuy Spine, Inc. Cross-linked polysaccharide drug carrier
US7449180 Feb 6, 2001 Nov 11, 2008 John Kisiday Macroscopic scaffold containing amphiphilic peptides encapsulating cells
US9597432 * Mar 1, 2011 Mar 21, 2017 Fujifilm Corporation Cell construct comprising polymer blocks having biocompatibility and cells
US20020160471 * Feb 6, 2001 Oct 31, 2002 John Kisiday Peptide scaffold encapsulation of tissue cells and uses thereof
US20120329157 * Mar 1, 2011 Dec 27, 2012 Fujifilm Corporation Cell construct comprising polymer blocks having biocompatibility and cells
CN103785065A * Jan 24, 2014 May 14, 2014 北京大清生物技术有限公司 Preparation method of cartilage regeneration scaffold material
International Classification A61L27/38, A61F2/02, A61F2/46, A61L27/48, A61L27/54, A61L27/36, A61F2/36, A61F2/30, A61L27/58, A61F2/28, A61L27/56, A61F2/00
Cooperative Classification A61F2002/2839, A61L27/38, A61L27/56, A61L27/58, A61F2/3601, A61F2002/30461, A61L27/48, A61L27/54, A61F2220/0075, A61L2300/414, A61F2002/2817, A61F2/4601, A61F2230/0082, A61L2300/604, A61F2002/30677, A61F2002/30261, A61F2/28, A61F2210/0004, A61F2250/0067, A61F2002/4649, A61F2/30756, A61F2002/30062
European Classification A61L27/48, A61F2/30C, A61F2/46A, A61L27/38, A61F2/28, A61L27/58, A61L27/54, A61L27/56